Richard Segal

Partner
Full contact info

I bring experience, practicality, and a lot of energy to make transformative capital markets transactions smooth, painless and fun.

Passions

Big mountains

Deep snow

Experience

Abivax Announces $235.8 Million IPO

October 20, 2023

Cooley advised Abivax, a clinical-stage biotech company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases, on its $235.8 million initial public offering.

Read more

Related contacts

Div Gupta
Partner, New York
Marc Recht
Partner, Boston
Ryan Sansom
Partner, Boston
Denny Won
Partner, San Francisco
Aaron Pomeroy
Partner, Colorado
Richard Segal
Partner, New York
Nyron J. Persaud
Partner, New York
Madhuri Roy
Partner, Palo Alto
Courtney Thorne
Partner, Boston
Elizabeth Anne Wright
Partner, Brussels
Xander Lee
Partner, Los Angeles Santa Monica
Phil Mitchell
Partner, New York
Stephanie Gentile
Partner, New York
Kevin King
Partner, Washington DC
Katie Kazem
Partner, Reston
Natasha Leskovsek
Of Counsel, Washington DC
Rebecca Ross
Special Counsel, Washington DC
Randy Sabett
Special Counsel, Washington DC
Jennifer Shanley
Special Counsel, New York
Reid Hooper
Special Counsel, Washington DC
Karen Tsai
Special Counsel, Washington DC
Minkyu Park
Associate, New York
Jesse Schulman
Associate, Washington DC
Barry Kuang
Associate, Boston
Olivia Creser
Associate, New York
Peter A. Haddad
Associate, San Diego
Samuel Paullin
Associate, Chicago
Evan Leitner
Associate, New York
Rick Jantz
Associate, Los Angeles Santa Monica
Cara Buchicchio
Associate, New York
Jason Valentine
Associate, Washington DC
Jessica Koffel
Associate, Brussels
Mor Agam
Associate, New York
Cathy Rude
Senior Paralegal, Boston

Related Practices & Industries

Immunology Company argenx Announces $1.27 Billion Global Offering

July 26, 2023

Cooley advised J.P. Morgan, Morgan Stanley, Goldman Sachs, BofA Securities and TD Cowen, representatives of the several underwriters, in the $1.27 billion follow-on offering by argenx SE, a global immunology company.

Read more

Related contacts

Richard Segal
Partner, New York
Div Gupta
Partner, New York
Darah Protas
Associate, Washington DC
Charles York
Associate, New York
Katie Lapidus
Associate, Washington DC
Carley Cruea
Associate, Washington DC
Bill Christiansen
Partner, Seattle
Phil Mitchell
Partner, New York
Natasha Leskovsek
Of Counsel, Washington DC
Jennifer Shanley
Special Counsel, New York
Dr. Tian Yong Zheng
Patent Agent, Seattle

Related Practices & Industries

Liminal BioSciences to Be Acquired by Structured Alpha

July 13, 2023

Cooley advised Liminal BioSciences, a Canada-based development-stage biopharmaceutical companylisted on Nasdaq, on its all-cash cross-border sale to Structured Alpha, a fund managed by Thomvest Asset Management

Read more

Related contacts

Kevin Cooper
Partner, New York
Richard Segal
Partner, New York
Christine Tse
Associate, New York

Related Practices & Industries

Prelude Therapeutics – $100 Million Follow-on Offering

May 18, 2023

Cooley advised the underwriters in Prelude Therapeutics’ $100 million follow-on offering. Prelude Therapeutics is a clinical-stage precision oncology company developing innovative drug candidates targeting critical cancer cell pathways. Lawyers Richard Segal, Div Gupta, Darah Protas, Sam Paullin and Katie Lapidus led the Cooley team.

Related contacts

Richard Segal
Partner, New York
Virat Gupta
Associate, Washington DC
Darah Protas
Associate, Washington DC
Samuel Paullin
Associate, Chicago
Katie Lapidus
Associate, Washington DC

Related Practices & Industries

Aura Biosciences – $86.7 Million Follow-on Offering

November 30, 2022

Cooley advised the underwriters in Aura Biosciences’ $86.7 million follow-on offering. SVB Securities, Cowen and Evercore ISI acted as joint bookrunning managers for the offering. Aura is a clinical-stage biotechnology company that is leveraging its novel targeted oncology platform to develop a potential new standard of care across multiple cancer indications, with an initial focus on ocular and urologic oncology. Partners Rich Segal, Div Gupta and Daniel Goldberg led the Cooley team.

Related contacts

Richard Segal
Partner, New York
Div Gupta
Partner, New York
Daniel I. Goldberg
Partner, New York
Evan Leitner
Associate, New York
Jesse Schulman
Associate, Washington DC
Kindall G. Jackson
Associate, Washington DC

Related Practices & Industries

View more

Rankings & accolades

Chambers USA: Capital Markets: Debt & Equity – Eastern United States - Nationwide (2023)

Chambers USA: Capital Markets – Massachusetts (2020 – 2022)

The Legal 500 US: Next Gen Partner for Capital Markets: Equity Offerings (2021 – 2023)

Massachusetts Super Lawyers: Rising Star – Securities & Corporate Finance (2013 – 2022)

He knows how to get deals done, has great judgment, and he understands the client really well.

Chambers USA